checkpoint inhibitors Archives - Page 24 of 25

Meet CRI’s New CEO Alicia Zhou, PhD

Why CRI
- Our Purpose
- Our Approach
- Our Leadership
- About CRI
- Resources
  - Events
  - Blog
  - Media Room
  - Annual Reports
  - FAQs
This is your opportunity to help create a world immune to cancer

Join us and the world’s leading scientists in the pursuit of life saving immunotherapies that will forever change how we treat cancer, from the inside out.

DONATE NOW
Immunotherapy
- Overview
  - Immunotherapy at a Glance
  - Immunotherapy In-Depth
- Resource Center
- Immunotherapy Stories
  - Patients
This is your opportunity to help create a world immune to cancer

Join us and the world’s leading scientists in the pursuit of life saving immunotherapies that will forever change how we treat cancer, from the inside out.

DONATE NOW
Who We Serve
- Scientists
- Patients
This is your opportunity to help create a world immune to cancer

Join us and the world’s leading scientists in the pursuit of life saving immunotherapies that will forever change how we treat cancer, from the inside out.

DONATE NOW
Take Action
- Donate
- Fundraise
- Participate
- Become a Partner
This is your opportunity to help create a world immune to cancer

Join us and the world’s leading scientists in the pursuit of life saving immunotherapies that will forever change how we treat cancer, from the inside out.

DONATE NOW

Why CRI
- Our Purpose
- Our Approach
- Our Leadership
- About CRI
- Resources
  - Events
  - Blog
  - Media Room
  - Annual Reports
  - FAQs
This is your opportunity to help create a world immune to cancer

Join us and the world’s leading scientists in the pursuit of life saving immunotherapies that will forever change how we treat cancer, from the inside out.

DONATE NOW
Immunotherapy
- Overview
  - Immunotherapy at a Glance
  - Immunotherapy In-Depth
- Resource Center
- Immunotherapy Stories
  - Patients
This is your opportunity to help create a world immune to cancer

Join us and the world’s leading scientists in the pursuit of life saving immunotherapies that will forever change how we treat cancer, from the inside out.

DONATE NOW
Who We Serve
- Scientists
- Patients
This is your opportunity to help create a world immune to cancer

Join us and the world’s leading scientists in the pursuit of life saving immunotherapies that will forever change how we treat cancer, from the inside out.

DONATE NOW
Take Action
- Donate
- Fundraise
- Participate
- Become a Partner
This is your opportunity to help create a world immune to cancer

Join us and the world’s leading scientists in the pursuit of life saving immunotherapies that will forever change how we treat cancer, from the inside out.

DONATE NOW

Filter stories by:

What Cancer Patients Need to Know About the Opdivo Approval

March 13, 2015December 14, 2022 Emily Helck

Big News: FDA Approves Opdivo (Nivolumab) for Lung Cancer

March 4, 2015December 14, 2022 Matthew Tontonoz

Immune Checkpoint Inhibitors: What’s Next?

February 9, 2015December 14, 2022 Alexandra Mulvey

Phase 3 Trial of Nivolumab Shows Survival Advantage in Lung Cancer

January 13, 2015December 14, 2022 Matthew Tontonoz

New Cancer Immunotherapy Opdivo Approved by FDA

December 22, 2014December 14, 2022 Jill O'Donnell-Tormey, PhD

ASH14 Preview: Blood Cancer Developments

December 1, 2014December 14, 2022 Jill O'Donnell-Tormey, PhD

1 … 22 23 24 25

This website uses tracking technologies, such as cookies, to provide a better user experience. If you continue to use this site, then you acknowledge our use of tracking technologies. For additional information, review our Privacy Policy.